Clinical Trial Update: Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of the fixed-dose combination sofosbuvir/ledipasvir in adolescents with chronic hepatitis C; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: Egyptian Liver Hospital | Conditions: Hepatitis C Virus Infection, Response to Therapy of | Phase 3 | Status: UNKNOWN